Lumexa Imaging Hldgs Analyst Price Targets

Wall Street analyst price targets and consensus rating for Lumexa Imaging Hldgs (LMRI).

Price Target Range — 4 Quarters

Analyst Consensus — 9 Analysts

1S.Buy

8Buy

Consensus RatingOverweight# Analysts9Avg. Consensus PT$21Upside to Avg. PT+90.7%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 5, 2026	Truist Securities	Clarke Murphy	Initiate	Buy	$18
Sep 25, 2026	Keybanc	Matthew Gillmor	Initiate	Overweight	$18
Aug 28, 2026	Barclays	Andrew Mok	PT Raise	Overweight	$9→$13
May 20, 2026	Barclays	Andrew Mok	PT Cut	Overweight	$15→$9
Apr 14, 2026	Barclays	Andrew Mok	PT Cut	Overweight	$23→$15
Feb 9, 2026	Raymond James	John Ransom	Upgrade	Outperform→Strong Buy	$23
Jan 5, 2026	Raymond James	John Ransom	Initiate	Outperform	$23
Jan 5, 2026	Barclays	—	Initiate	Overweight	$23
Jan 5, 2026	Wells Fargo	—	Initiate	Overweight	$22
Jan 5, 2026	William Blair	Ryan Daniels	Initiate	Outperform	—
Jan 5, 2026	Deutsche Bank	Pito Chickering	Initiate	Buy	$22
Jan 5, 2026	Leerink Partners	—	Initiate	Outperform	$23
Jan 5, 2026	Jefferies	Brian Tanquilut	Initiate	Buy	$23

More with Benzinga EdgeGet Access

Analyst Ratings News

This Vertiv Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

Analysts initiated bullish coverage on VRT, VYLR, ATHR, LMRI and NVT, assigning Buy or Outperform ratings and price targets.

Avi Kapoor

PRO
Truist Securities Initiates Coverage On Lumexa Imaging Hldgs with Buy Rating, Announces Price Target of $18

Truist Securities analyst Clarke Murphy initiates coverage on Lumexa Imaging Hldgs (NASDAQ:LMRI) with a Buy rating and announces Price Target of $18.

Benzinga Newsdesk

PRO
Keybanc Initiates Coverage On Lumexa Imaging Hldgs with Overweight Rating, Announces Price Target of $18

Keybanc analyst Matthew Gillmor initiates coverage on Lumexa Imaging Hldgs (NASDAQ:LMRI) with a Overweight rating and announces Price Target of $18.

Benzinga Newsdesk

PRO
Barclays Maintains Overweight on Lumexa Imaging Hldgs, Raises Price Target to $13

Barclays analyst Andrew Mok maintains Lumexa Imaging Hldgs (NASDAQ:LMRI) with a Overweight and raises the price target from $9 to $13.

Benzinga Newsdesk

PRO
Barclays Maintains Overweight on Lumexa Imaging Hldgs, Lowers Price Target to $9

Barclays analyst Andrew Mok maintains Lumexa Imaging Hldgs (NASDAQ:LMRI) with a Overweight and lowers the price target from $15 to $9.

Benzinga Newsdesk

PRO
Barclays Maintains Overweight on Lumexa Imaging Hldgs, Lowers Price Target to $15

Barclays analyst Andrew Mok maintains Lumexa Imaging Hldgs (NASDAQ:LMRI) with a Overweight and lowers the price target from $23 to $15.

Benzinga Newsdesk

Lumexa Imaging Holdings Inc

Lumexa Imaging Hldgs Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

This Vertiv Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

PRO
Truist Securities Initiates Coverage On Lumexa Imaging Hldgs with Buy Rating, Announces Price Target of $18

PRO
Keybanc Initiates Coverage On Lumexa Imaging Hldgs with Overweight Rating, Announces Price Target of $18

PRO
Barclays Maintains Overweight on Lumexa Imaging Hldgs, Raises Price Target to $13

PRO
Barclays Maintains Overweight on Lumexa Imaging Hldgs, Lowers Price Target to $9

PRO
Barclays Maintains Overweight on Lumexa Imaging Hldgs, Lowers Price Target to $15

People Also Watch

People Also Watch

Lumexa Imaging Holdings Inc

Lumexa Imaging Hldgs Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

This Vertiv Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

PROTruist Securities Initiates Coverage On Lumexa Imaging Hldgs with Buy Rating, Announces Price Target of $18

PROKeybanc Initiates Coverage On Lumexa Imaging Hldgs with Overweight Rating, Announces Price Target of $18

PROBarclays Maintains Overweight on Lumexa Imaging Hldgs, Raises Price Target to $13

PROBarclays Maintains Overweight on Lumexa Imaging Hldgs, Lowers Price Target to $9

PROBarclays Maintains Overweight on Lumexa Imaging Hldgs, Lowers Price Target to $15

People Also Watch

People Also Watch

PRO
Truist Securities Initiates Coverage On Lumexa Imaging Hldgs with Buy Rating, Announces Price Target of $18

PRO
Keybanc Initiates Coverage On Lumexa Imaging Hldgs with Overweight Rating, Announces Price Target of $18

PRO
Barclays Maintains Overweight on Lumexa Imaging Hldgs, Raises Price Target to $13

PRO
Barclays Maintains Overweight on Lumexa Imaging Hldgs, Lowers Price Target to $9

PRO
Barclays Maintains Overweight on Lumexa Imaging Hldgs, Lowers Price Target to $15